Société NGM Biopharmaceuticals, Inc.
Actions
NGM
US62921N1054
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,54 USD | -1,28% | 0,00% | +79,28% |
Métier
Nombre d'employés: 138
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
David Woodhouse
CEO | Chief Executive Officer | 54 | 02/03/15 |
William Rieflin
CHM | Chairman | 64 | 01/09/10 |
Daniel Kaplan
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/08 |
William Chang
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/19 |
Hsiao Lieu
CTO | Chief Tech/Sci/R&D Officer | 53 | 01/03/19 |
Valerie Pierce
CMP | Compliance Officer | 61 | 29/10/19 |
David Goeddel
BRD | Director/Board Member | 72 | 01/01/08 |
Joyce Q. Acbay
LAW | General Counsel | - | 01/04/20 |
Irene Perlich
AUD | Comptroller/Controller/Auditor | - | 01/03/21 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Roger Perlmutter
BRD | Director/Board Member | 71 | 08/06/21 |
David Goeddel
BRD | Director/Board Member | 72 | 01/01/08 |
William Rieflin
CHM | Chairman | 64 | 01/09/10 |
David Woodhouse
CEO | Chief Executive Officer | 54 | 02/03/15 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 83 462 408 | 81 886 322 ( 98,11 %) | 0 | 98,11 % |
Coordonnées société
NGM Biopharmaceuticals, Inc.
333 Oyster Point Boulevard
94080-7014, South San Francisco
+650 243 5555
http://www.ngmbio.comSecteur
Varia. 1 janv. | Capi. | |
---|---|---|
+79,28% | 129 M | |
-2,31% | 103 Md | |
+0,56% | 95,28 Md | |
+1,69% | 22,15 Md | |
-17,37% | 21,02 Md | |
-9,30% | 18,15 Md | |
-41,01% | 16,74 Md | |
-14,85% | 16,05 Md | |
+3,21% | 13,68 Md | |
+33,54% | 12,17 Md |
- Bourse
- Actions
- Action NGM
- Société NGM Biopharmaceuticals, Inc.